Company profile · Sponsor
Ars
Ars Pharmaceuticals Irl Limited
- Pipeline
- 8
- Drugs
- 1
- Patents
- 0
Quick answer
Ars (SPRY) is a pharma company. headquartered in SAN DIEGO, CA, GB. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 1 drug, and 0 patents to this profile..
Company facts
Pipeline (8)
Search pipeline →-
SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM
Ars
Amyotrophic Lateral Sclerosis
1 trial -
ARS-1
Ars
Asthma
1 trial -
ARS-1
Ars
Urticaria
1 trial -
EPINEPHRINE NASAL SPRAY, Placebo Nasal Spray, EPINEPHRINE NASAL SPRAY
Ars
Chronic Spontaneous Urticaria (CSU)
1 trial -
Placebo
Ars
Urticaria Chronic
1 trial -
ARS-1 with URTI
Ars
Upper Respiratory Tract Infection
1 trial -
IXCHIQ
Ars
Chikungunya Virus Infection
1 trial -
Neffy
Ars
Allergic Reactions
1 trial
Drugs (1)
Search drugs →Frequently asked questions
What is Ars?
Ars (SPRY) is a pharma company. headquartered in SAN DIEGO, CA, GB. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 1 drug, and 0 patents to this profile..
What pipeline programs does Ars sponsor?
We track 8 ClinicalTrials.gov-linked programs for Ars, including SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM and 7 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Ars company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.